The prevention effect of losartan on the AngII-reduced AdipoR1 expression will provide further understanding of the pathogenesis of cardiac hypertrophy and provide novel insights into this anti-remodeling therapy. This evidence concerns the gene AGT and cardiac hypertrophy.